Internal Server Error

Aptamer Group - About the company

Aptamer Group is a public company based in York (United Kingdom), founded in 2008. It operates as a Manufacturer of DNA and RNA nucleic acid aptamers for use in research & development. Aptamer Group has raised $2.2M in funding from Meneldor. The company has 26 active competitors, including 4 funded and 6 that have exited. Its top competitors include companies like Aptamer Sciences, Base Pair Biotechnologies and Apta Biotech.

Company Details

Manufacturer of DNA and RNA nucleic acid aptamers for use in research & development. The company develops aptamer molecules derived from nucleic acids by using Optimer technology that functions as an antibody alternative. The Optimer binders are used for research and tool reagents, biomarker discovery and diagnostic development, and as therapeutic lead compounds.
Social
XFacebook
Email ID
*****@aptamergroup.com
Phone Number
+44 **********
Key Metrics
Founded Year
2008
Location
Stage
Public
Total Funding
$2.2M in 5 rounds
Latest Funding Round
Investors
Ranked
Annual Revenue
£1M - £10M as on Jun 30, 2025
Employee Count
46 as on Oct 31, 2026
Similar Companies
Exit Details
Public

Aptamer Group's IPO details

Aptamer Group got listed on Dec 22, 2021.
Click here to take a look at Aptamer Group's IPO in detail
Sign up to download Aptamer Group's company profile

Aptamer Group's funding and investors

Aptamer Group has raised a total funding of $2.2M over 5 rounds. Its first funding round was on Jun 26, 2018. Aptamer Group has 5 institutional investors.

Here is the list of recent funding rounds of Aptamer Group:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Jul 04, 2025
7794156
Post IPO
9683981
4050134
1937334
2975349
Jul 24, 2024
4808607
Post IPO
5196165
5337446
2048820
Sep 19, 2023
5084010
Post IPO
7766808
7027478
3305564
3573385
lockAccess funding benchmarks and valuations. Sign up today!

Aptamer Group's founders and board of directors

Founder? Claim Profile

Aptamer Group's employee count trend

Aptamer Group has 46 employees as of Oct 26. Here is Aptamer Group's employee count trend over the years:
Employee count trend for Aptamer Group
lockUncover Aptamer Group's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Aptamer Group's Competitors and alternates

Top competitors of Aptamer Group include Aptamer Sciences, Base Pair Biotechnologies and Apta Biotech. Here is the list of Top 10 competitors of Aptamer Group, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Aptamer Group
Aptamer Group
2008, York (United Kingdom), Public
Manufacturer of DNA and RNA nucleic acid aptamers for use in research & development
$2.2M
59/100
2nd
Logo for Aptamer Sciences
Aptamer Sciences
2011, Pohang si (South Korea), Public
Aptamer technology platform for protein analysis
-
49/100
3rd
Aptamer discovery and development services for diagnostics, therapeutics, and research
$5.06M
42/100
4th
Logo for Apta Biotech
Apta Biotech
2009, Yongin si (South Korea), Public
Provider and developer of aptamers based on platform technology
-
36/100
5th
Logo for Femtogenix
Femtogenix
2015, London (United Kingdom), Series B
Provider of DNA-interactive payload molecules for use in ADCs
$40.2M
 
35/100
6th
Logo for Apta Biosciences
Apta Biosciences
2013, London (United Kingdom), Deadpooled
Developer of a synthetic biology technology platform for diagnostics and therapeutics
$4.51M
34/100
7th
Logo for Aptus Biotech
Aptus Biotech
2010, Madrid (Spain), Seed
Developer of biotechnological applications based on aptamers
-
33/100
8th
Logo for Xenolis
Xenolis
2022, Singapore (Singapore), Unfunded
Provider of a platform for discovery and development of XenoAptamers for life sciences applications and research
-
-
32/100
9th
Logo for Archemix
Archemix
2000, San Francisco (United States), Deadpooled
Aptamer therapeutics for rare hematological diseases
$102M
31/100
10th
Logo for Aptabodies.com
Aptabodies.com
2008, York (United States), Unfunded
Develops and manufactures aptamers
-
-
30/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Aptamer Group's competitors? Click here to see the top ones

Aptamer Group's Investments and acquisitions

Aptamer Group has made no investments or acquisitions yet.

Reports related to Aptamer Group

Here is the latest report on Aptamer Group's sector:

News related to Aptamer Group

lockFilter this list
Media has covered Aptamer Group for a total of 14 events in the last 1 year, 9 of them have been about company updates and 1 about people movement.
•
Aptamer Group grows sales pipeline to £7m as it targets break-evenTheBusinessDesk.com•Oct 13, 2026•Aptamer Group
•
Aptamer Group set to report strong growth - reflects “continuedInsider Media•Jul 14, 2026•Aptamer Group
•
Aptamer revenues climb as York biotech delivers first licensing incomeTheBusinessDesk.com•Jul 13, 2026•Aptamer Group
•
Aptamer Group Begins Development of Rapid Test for Bundibugyo EbolaContract Pharma•Jul 08, 2026•Aptamer Group
•
Aptamer Announces First-Half Progress and Plans to Raise FundsShareprices•Mar 25, 2026•Aptamer Group
•
Aptamer Group Introduces Targeted Radiopharmaceutical ProgramContract Pharma•Mar 18, 2026•Aptamer Group
•
Aptamer lifts revenues as licensing strategy gains momentumTheBusinessDesk.com•Jan 07, 2026•Aptamer Group
•
Aptamer signs Optimer contract with US biotech AlphazymeShareprices•Dec 23, 2025•Aptamer Group, Alphazyme
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Aptamer Group

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford